Melphalan Injection and Proglumetacin: Interaction Details
- Melphalan Injection
- EvomelaAlkeranHepzato +1 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Melphalan Injection and Proglumetacin interaction:
Melphalan Injection
- Evomela
- Alkeran
- Hepzato
- Ivra
Proglumetacin
We don't have a drug information page for Proglumetacin yet. Have a question about Proglumetacin? Ask a pharmacist, free →
What Happens When You Take Melphalan Injection With Proglumetacin
What can happen when they are taken together (rated Major)
An increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Giving melphalan together with can raise the likelihood of bleeding. Agents that alter function, NSAIDs among them, should be stopped one week prior to the melphalan procedure.1
The Melphalan Injection and Proglumetacin Interaction, Explained
Melphalan is a chemotherapy medicine that can lower your blood counts, including the that help your blood clot. Proglumetacin is an (a pain and inflammation reliever) that also makes platelets work less well. Taken together, they may add up and raise your chance of bleeding, like easy bruising, nosebleeds, or bleeding that is slow to stop.
This concern is mostly based on how the drugs work, not on many reported cases. Still, it is listed as a major interaction. Please don't stop or change anything on your own. Tell your pharmacist or cancer care team that you take proglumetacin so they can plan around it. They can manage this with careful timing and monitoring.
Interaction: Melphalan plus proglumetacin (an , indomethacin and glucosamine ester) may increase bleeding risk through effects on hemostasis.
- Mechanism: Melphalan-related () plus NSAID COX-1 of thromboxane A2 production, with possible mucosal injury. This is , not a PK interaction.
- Evidence: Theoretical. Onset unspecified. Severity on file: major.
- Management: Per labeling, discontinue drugs affecting platelet function, such as , one week before the melphalan procedure. Monitor platelet counts and for signs of bleeding. Individualize the plan with the patient's oncology team.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Melphalan Injection and Proglumetacin Interact
The likely mechanism
effects on hemostasis
How to Manage the Melphalan Injection and Proglumetacin Interaction
Your care team can manage this by planning ahead. The documented guidance is that , which affect function, are discontinued one week before a procedure with melphalan.
- Do not stop or change proglumetacin on your own. Ask your prescriber or pharmacist when and whether to pause it.
- Tell your team about all pain relievers you use, including over-the-counter ones.
- Your team may monitor you more closely for bleeding.
- Report unusual bruising, nosebleeds, black stools, or bleeding that won't stop.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Melphalan Injection or Proglumetacin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Melphalan Injection and Proglumetacin: Common Questions
How serious is the Melphalan Injection and Proglumetacin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Melphalan Injection and Proglumetacin interaction managed?
Your care team can manage this by planning ahead. The documented guidance is that , which affect function, are discontinued one week before a procedure with melphalan. Do not stop or change proglumetacin on your own. Ask your prescriber or pharmacist when and whether to pause it. Tell your team about all pain relievers you use, including over-the-counter ones. Your team may monitor… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Melphalan Injection and Proglumetacin Interaction
Ask in your own words about taking Melphalan Injection and Proglumetacin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: HEPZATO intraartieral injection, melphalan intraarterial injection. Delcath Systems Inc (per FDA), Queensbury, NY, 2023.
Other Serious Interactions of Melphalan Injection and Proglumetacin
Also serious with Melphalan Injection
Also serious with Proglumetacin
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.